William S. Bowen

822 total citations
17 papers, 578 citations indexed

About

William S. Bowen is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, William S. Bowen has authored 17 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in William S. Bowen's work include Immune Response and Inflammation (4 papers), Pancreatic function and diabetes (4 papers) and Kidney Stones and Urolithiasis Treatments (3 papers). William S. Bowen is often cited by papers focused on Immune Response and Inflammation (4 papers), Pancreatic function and diabetes (4 papers) and Kidney Stones and Urolithiasis Treatments (3 papers). William S. Bowen collaborates with scholars based in United States and United Kingdom. William S. Bowen's co-authors include Carl L. Nelson, Haval Shirwan, Lalit Batra, Hampartsoum B. Barsoumian, Esma S. Yolcu, Jay T. Evans, David A. Johnson, Pradeep Shrestha, Hong Zhao and Thomas C. Mitchell and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Nature Materials.

In The Last Decade

William S. Bowen

16 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William S. Bowen United States 10 220 159 141 89 79 17 578
Issaka Yougbaré Canada 13 177 0.8× 236 1.5× 69 0.5× 48 0.5× 54 0.7× 23 847
Philip Lowry United States 11 132 0.6× 200 1.3× 67 0.5× 71 0.8× 152 1.9× 28 651
Chrisna Durandt South Africa 15 92 0.4× 191 1.2× 79 0.6× 53 0.6× 75 0.9× 35 710
Indra Bachtiar Indonesia 13 61 0.3× 146 0.9× 51 0.4× 21 0.2× 47 0.6× 37 497
Ana Cordeiro Gomes Portugal 12 278 1.3× 187 1.2× 45 0.3× 28 0.3× 163 2.1× 19 851
Katleen Broos Belgium 11 61 0.3× 134 0.8× 111 0.8× 34 0.4× 29 0.4× 18 727
Huaping Xiao China 13 433 2.0× 208 1.3× 66 0.5× 43 0.5× 369 4.7× 27 869
Dorota Pastuszak‐Lewandoska Poland 18 131 0.6× 321 2.0× 48 0.3× 104 1.2× 159 2.0× 72 790
Michael Liu United States 12 462 2.1× 177 1.1× 180 1.3× 39 0.4× 189 2.4× 20 989
Taiki Suzuki Japan 16 46 0.2× 286 1.8× 210 1.5× 93 1.0× 113 1.4× 64 966

Countries citing papers authored by William S. Bowen

Since Specialization
Citations

This map shows the geographic impact of William S. Bowen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William S. Bowen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William S. Bowen more than expected).

Fields of papers citing papers by William S. Bowen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William S. Bowen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William S. Bowen. The network helps show where William S. Bowen may publish in the future.

Co-authorship network of co-authors of William S. Bowen

This figure shows the co-authorship network connecting the top 25 collaborators of William S. Bowen. A scholar is included among the top collaborators of William S. Bowen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William S. Bowen. William S. Bowen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Williams, James C., William S. Bowen, James E. Lingeman, et al.. (2024). Two distinct phenotypes of calcium oxalate stone formers could imply different long-term risks for renal function. Urolithiasis. 52(1). 133–133. 2 indexed citations
2.
Bowen, William S., Ricardo Melo Ferreira, Farooq Syed, et al.. (2023). A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease. Nature Communications. 14(1). 4140–4140. 37 indexed citations
3.
Sabo, Angela R., William S. Bowen, Ricardo Melo Ferreira, et al.. (2022). A Spatially Anchored Transcriptomic Atlas of the Human Kidney Papilla Identifies Significant Immune Injury and Matrix Remodeling in Stone Disease Patients. Journal of the American Society of Nephrology. 33(11S). 20–21.
4.
Barsoumian, Hampartsoum B., Lalit Batra, Pradeep Shrestha, et al.. (2019). A Novel Form of 4-1BBL Prevents Cancer Development via Nonspecific Activation of CD4+ T and Natural Killer Cells. Cancer Research. 79(4). 783–794. 14 indexed citations
6.
Headen, Devon M., Kyle B. Woodward, María M. Coronel, et al.. (2018). Local immunomodulation with Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance. Nature Materials. 17(8). 732–739. 138 indexed citations
7.
Shrestha, Pradeep, William S. Bowen, Lalit Batra, et al.. (2018). CD47 Overcomes Early Loss of Pancreatic Islet Grafts Transplanted Intraportally. Transplantation. 102(Supplement 7). S47–S47. 1 indexed citations
8.
Bowen, William S., et al.. (2018). Current challenges for cancer vaccine adjuvant development. Expert Review of Vaccines. 17(3). 207–215. 118 indexed citations
9.
Shirwan, Haval, Kyle B. Woodward, Devon M. Headen, et al.. (2018). SA-FasL-engineered PEG microgels as a novel means of modulating immune response to allogeneic islet grafts. The Journal of Immunology. 200(Supplement_1). 55.36–55.36. 2 indexed citations
10.
Batra, Lalit, Pradeep Shrestha, Esma S. Yolcu, et al.. (2018). The Transient Display of a Chimeric PD-L1 Protein on Pancreatic Islets Promotes Indefinite Survival in Allogeneic Recipients. Transplantation. 102(Supplement 7). S455–S455. 2 indexed citations
11.
Bowen, William S., Hélène G. Bazin, Kendal Ryter, et al.. (2014). Characterization of TRIF selectivity in the AGP class of lipid A mimetics: Role of secondary lipid chains. Bioorganic & Medicinal Chemistry Letters. 25(3). 547–553. 6 indexed citations
12.
Bowen, William S., Siva K. Gandhapudi, Joseph P. Kolb, & Thomas C. Mitchell. (2013). Immunopharmacology of Lipid A Mimetics. Advances in pharmacology. 66. 81–128. 6 indexed citations
13.
Bowen, William S., et al.. (2012). Selective TRIF-Dependent Signaling by a Synthetic Toll-Like Receptor 4 Agonist. Science Signaling. 5(211). ra13–ra13. 64 indexed citations
14.
Bazin, Hélène G., William S. Bowen, Afsaneh Mozaffarian, et al.. (2008). The ‘Ethereal’ nature of TLR4 agonism and antagonism in the AGP class of lipid A mimetics. Bioorganic & Medicinal Chemistry Letters. 18(20). 5350–5354. 21 indexed citations
15.
Bowen, William S., et al.. (2004). Interaction of Thiostrepton and Elongation Factor-G with the Ribosomal Protein L11-binding Domain. Journal of Biological Chemistry. 280(4). 2934–2943. 34 indexed citations
16.
Bowen, William S., Walter E. Hill, & J. Stephen Lodmell. (2001). Comparison of rRNA Cleavage by Complementary 1,10-Phenanthroline-Cu(II)- and EDTA-Fe(II)-Derivatized Oligonucleotides. Methods. 25(3). 344–350. 10 indexed citations
17.
Nelson, Carl L. & William S. Bowen. (1986). Total hip arthroplasty in Jehovahʼs Witnesses without blood transfusion.. Journal of Bone and Joint Surgery. 68(3). 350–353. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026